Biological and clinical heterogeneity of B-cell chronic lymphocytic leukemia

Leukemia and Lymphoma

Volumn 44, Issue 2, 2003, Pages 223-228

  D'Arena, Giovanni ^a   Di Renzo, Nicola ^a   Brugiatelli, Maura ^b   Vigliotti, Maria L ^a   Keating, Michael J ^c  

^a REFERRAL CANCER CENTER OF BASILICATA   (Italy)

^b Azienda Ospedaliera Papardo   (Italy)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

B cell chronic lymphocytic leukemia; CD38; Heterogeneity; IgV mutation

Indexed keywords

ANTIGEN; CD38 ANTIGEN;

B CELL LEUKEMIA; BLOOD; BONE MARROW; CANCER CLASSIFICATION; CANCER STAGING; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL FEATURE; GENE MUTATION; GENETIC HETEROGENEITY; GERMINAL CENTER; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOGLOBULIN VARIABLE REGION; IMMUNOPHENOTYPING; LYMPH FOLLICLE; LYMPHATIC SYSTEM; LYMPHOCYTE ACTIVATION; LYMPHOPROLIFERATIVE DISEASE; MEMORY CELL; MOLECULAR GENETICS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REVIEW; WESTERN HEMISPHERE;

ANTIGENS, CD; HUMANS; IMMUNOGLOBULIN VARIABLE REGION; IMMUNOPHENOTYPING; LEUKEMIA, B-CELL, CHRONIC;

EID: 0037303478     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/1042819021000035756     Document Type: Review

References (65)

1. Harris, N.L., Jaffe, E.S., Diebold, J., Flandrin, G., Muller-Hermelink, H.K., Vardiman, J., Lister, T.A. and Bloomfield, C.D. (1999) "World Health Organization Classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the clinical advisory committee meeting-Airlie House, Virginia, November 1997", Journal of Clinical Oncology 17, 3835-3849.
2. Harris, N.L., Jaffe, E.S., Stein, H., Banks, P.M., Chan, J.K.C., Cleary, M.L., Delsol, G., De Wolf-Peeters, C., Falini, B., Garter, K.C., Grogan, T.M., Isaacson, P.G., Knowles, D.M., Mason, D.Y., Muller-Hermelink, H.K., Pileri, S.A., Piris, M.A., Ralfkiaer, E., and Warnke, R.A. (1994) "A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group", Blood 84, 1361-1392.
3. D'Arena, G., Keating, M.J., and Carotenuto, M. (2000) "Chronic lymphoproliferative disorders: an integrated point of view for the differential diagnosis", Leukemia and Lymphoma 36, 225-237.
4. Kipps, T.J. (2001) "Chronic lymphocytic leukemia and related diseases", In: Beutler, E., eds, Williams Hematology (McGraw Hill, New York), pp. 1163-1194.
5. Molica, S. (2001) "Prognostic factors in chronic lymphocytic leukemia", In: Cheson, B.D., ed, Chronic Lymphoid Leukemias (Marcel Dekker, New York), pp. 231-260.
6. Rai, K.R., Sawitsky, A., Cronkite, E.P., Chanana, A., Levy, R. and Pasternak, K. (1975) "Clinical staging of chronic lymphocytiic leukemia", Blood 46, 219-234.
7. Binet, J.L., Auquier, A., Dighiero, G., Chastang, C., Piguet, H., Goasguen, J., Vaugier, G., Potron, G., Colona, P., Oberling, F., Thomas, M., Tchernia, G., Boivin, P., Lesty, C., Duault, M., Monconduit, M., Belabbes, S. and Gremy, F. (1981) "A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis", Cancer 48, 198-206.
8. Rai, K.R. (1987) "A critical analysis of staging in CLL", In: Gale, R.P. and Rai, K.R., eds, Chronic Lymphocytic Leukemia: Recent Progress and Future Directions (Alan R. Liss, New York).
9. Montserrat, E., Vinolas, N., Reverter, J.C. and Rozman, C. (1988) "Natural history of chronic lymphocytic leukemia: on the progression and prognosis of early stages", Nouvelle Revue Francaise de Hematologie 30, 359-362.
10. Bennett, J.M., Catovsky, D., Daniel, M.T., Flandrin, G., Galton, D.A.G., Gralnick, H.R. and Sultan, C. (1988) "The French-American-British (FAB) proposal for the classification of chronic (mature) B and T lymphoid leukaemias", Journal of Clinical Pathology 42, 567-584.
11. Molica, S. and Alberti, A. (1988) "Investigation of nuclear clefts as prognostic parameter in chronic lymphocytic leukemia", European Journal of Haematology 41, 62-65.
12. Vallespi, T., Montserrat, E. and Sanz, M.A. (1991) "Chronic lymphocytic leukaemia: prognostic value of lymphocyte morphological subtypes. A multivariate survival analysis of 146 patients", British Journal of Haematology 77, 478-485.
13. Hjalmar, V., Kimby, E., Matutes, E., Sundstrom, C., Jacobsson, B., Arvidsson, I. and Hast, R. (1998) "Trisomy 12 and lymphoplasmacytoid lymphocytes in chronic leukemic B-cell disorders", Haematologica 83, 602-609.
14. Gonzales, H., Maloum, K., Remy, F., Merle-Béral, H. and Lesty, C. (2002) "Cleaved lymphocytes in chronic lymphocytic leukemia: a detailed retrospective analysis of diagnostic features", Leukemia and Lymphoma 43, 555-564.
15. Criel, A., Verhoef, G., Vlietinck, R., Mecucci, C., Billiet, J., Michaux, L., Meeus, P., Louwagie, A., Van Orshoven, A., Van Hoof, A., Boogaerts, M., Van den Berghe, H. and De Wolf-Peeters, C., (1997) "Further characterization of morphologically defined typical and atypical CLL: a clinical, immunophenotypic, cytogenetic and prognostic study on 390 cases", British Journal of Haematology 97, 383-391.
16. Oscier, D.G., Matutes, E., Copplestone, A., Pickering, R.M., Chapman, R., Gillingham, R., Catovsky, D. and Hamblin, T.J. (1997) "Atypical lymphocyte morphology: an adverse prognostic factor for disease progression in stage A CLL independent of trisomy 12", British Journal of Haematology 98, 934-939.
17. Criel, A., Michaux, L. and De Wolf-Peeters, C. (1999) "The concept of typical and atypical chronic lymphocytic leukemia", Leukemia and Lymphoma 33, 33-45.
18. Frater, J.L., McCarron, K.F., Hammel, J.P., Shapiro, J.L., Miller, M.L., Tubbs, R.R., Pettay, J. and Hsi, E.D. (2001) "Typical and atypical chronic lymphocytic leukemia differ clinically and immunophenotypically", American Journal of Clinical Pathology 116, 655-664.
19. Gonzales, H., Maloum, K., Remy, F., Merle-Beral, H. and Lesty, C. (2002) "Cleaved lymphocytes in chronic lymphocytic leukemia: a detailed retrospective analysis of diagnostic features", Leukemia and Lymphoma 43, 555-564.
20. Matutes, E. and Polliack, A. (2000) "Morphological and immunophenotypic features of chronic lymphocytic leukemia", Reviews in Clinical and Experimental Hematology 4, 22-47.
21. Caligaris-Cappio, F. (1996) "B-chronic lymphocytic leukemia: a malignancy of anti-self B cells", Blood 87, 2615-2620.
22. Caligaris-Cappio, F. and Hamblin, T.J. (1999) "B-cell chronic lymphocytic leukemia: a bird of different feather", Journal of Clinical Oncology 17, 399-408.
23. D'Arena, G., Cascavilla, N. and Carotenuto, M. (2000) "Usefulness of quantitative flow cytometry and value of CD79b and CD38 detection for the characterization of chronic lymphoproliferative disorders", In: Carotenuto, M., eds, Recent advances in Hematology 2000, Grafica Baal, S. Giovanni Rotondo, pp 141-159.
24. D'Arena, G., Cascavilla, N., Musto, P., Matera, R. and Carotenuto, M. (2000) "Quantitative flow cytometry for the differential diagnosis of leukemic B-cell chronic lymphoproliferative disorders", American Journal of Hematology 64, 275-280.
25. D'Arena, G., Cascavilla, N., Musto, P., Di Renzo, N., Dell'Olio, M., Perla, G., Savino, L. and Greco, M.M. (2001) "Morphologically typical and atypical B-cell chronic lymphocytic leukemias display a different pattern of surface antigenic density", Leukemia and Lymphoma 42, 649-654.
26. Cohen, P.L., Kurtin, P.J., Donovan, K.A. and Hanson, P. (1997) "Immunophenotypic analysis in the distinction of small lymphocytic lymphoma/chronic lymphocytic leukemia from mantle cell lymphoma", American Journal of Clinical Pathology 105, 451-457.
27. Gong, J.Z., Lagoo, A.S., Peters, D., Horvatinovich, J., Benz, P. and Buckley, P.J. (2001) "Value of CD23 determination by flow cytometry in differentiating mantle cell lymphoma from chronic lymphocytic leukemia/small lymphocytic lymphoma", American Journal of Clinical Pathology 116, 893-897.
28. Di Raimondo, F., Albitar, M., Huh, Y., O'Brien, S., Montillo, M., Tedeschi, A., Kantarjian, H., Lerner, S., Giustolisi, R. and Keating, M. (2002) "The clinical and diagnostic relevance of CD23 expression in chronic lymphoproliferative disease", Cancer 94, 1721-1730.
29. Ahmad, E., Garcia, D. and Davis, B.H. (2002) "Clinical utility of CD23 and FMC7 antigen coexistent expression in B-cell lymphoproliferative disorder subclassification", Cytometry 50, 1-7.
30. Molica, S., Levato, D., Dattilo, A. and Mannella, A. (1998) "Clinico-prognostic relevance of quantitative immunophenotyping in B-cell chronic lymphocytic leukemia with emphasis on the expression of CD20 antigen and surface immunoglobulins", European Journal of Cancer 60, 47-52.
31. Ginaldi, L., De Martinis, M., Matutes, E., Farahat, N., Morilla, R. and Catovsky, D. (1998) "Levels of expression of CD19 and CD20 in chronic B cell leukaemias", Journal of Clinical Pathology 51, 364-369.
32. Ginaldi, L., De Martinis, M., Matutes, E., Farahat, N., Morilla, R., Dyer, M.J.S. and Catovsky, D. (1998) "Levels of expression of CD52 in normal and leukemic B and T cells: correlation with in vivo therapeutic responses to CAMPATH-1H", Leukemia Research 22, 185-191.
33. Golay, J., Lazzari, M., Facchinetti, V., Bernasconi, S., Borleri, G., Barbui, T., Rambaldi, A. and Introna, M. (2001) "CD20 levels determine the in vitro susceptibility to rituximab and complement of B-cell chronic lymphocytic leukemia: further regulation by CD55 and CD59", Blood 98, 3383-3389.
34. Pickartz, T., Ringel, F., Wedde, M., Renz, H., Klein, A., von Neuhoff, N., Dreger, P., Kreuzer, K.A., Schmidt, C.A., Srock, S., Schoeler, D. and Schriever, F. (20019) "Selection of B-cell chronic lymphocytic leukemia cell variants by therapy with anti-CD20 monoclonal antibody rituximab", Experimental Hematology 29, 1410-1416.
35. Bass, A.J., Gong, J., Nelson, R. and Rizzieri, D.A. (2002) "CD52 expression in mantle cell lymphoma", Leukemia and Lymphoma 43, 339-342.
36. Perz, J., Tolpay, J., Fruehauf, S., Hensel, M. and Ho, A.D. (2002) "Level of CD20-expression and efficacy of rituximab treatment in patients with resistant or relapsing B-cell prolymphocytic leukemia and B-cell chronic lymphocytic leukemia", Leukemia and Lymphoma 43, 149-151.
37. Keating, M.J., O'Brien, S. and Albitar, M. (2002) "Emerging information on the use of rituximab in chronic lymphocytic leukemia", Seminars in Oncology 29, 70-74.
38. Nabhan, C. and Rosen, S.T. (2002) "Conceptual aspects of combining rituximab and Campath-1H in the treatment of chronic lymphocytic leukemia", Seminars in Oncology 29, 75-80.
39. Juliusson, G., Oscier, D.G., Fitchett, M., Ross, F.M., Stockdill, G., Mackie, M.J., Parker, A.C., Castoldi, G.L., Cuneo, A., Knuutila, S., Elonen, E. and Gahrton, G. (1990) "Prognostic subgroups in B-cell chronic lymphocytic leukaemia defined by specific chromosomal abnormalities", New England Journal of Medicine 323, 720-724.
40. Matutes, E., Oscier, D., Garcia-Marco, J., Ellis, J., Copplestone, A., Gillingham, R., Hamblin, T., Lens, D., Swansbury, G.J. and Catovsky, D. (1996) "Trisomy 12 defines a group of CLL with atypical morphology: correlation between cytogenetic, clinical and laboratory features in 544 patients", British Journal of Haematology 92, 382-388.
41. Bigoni, R., Cuneo, A., Roberti, M.G., Bardi, A., Rigolin, G.M., Piva, N., Scapoli, G., Spanedda, R., Negrini, M., Bullrich, F., Veronese, M.L., Croce, C.M. and Castoldi, G. (1997) "Chromosome aberrations in atypical chronic lymphocytic leukemia: a cytogenetic and interphase cytogenetic study", Leukemia 11, 1933-1940.
42. Criel, A., Verhoef, G., Vlietinck, R., Mecucci, C., Billiet, J., Michaux, L., Meeus, P., Louwagie, A., Van Orshoven, A., Van Hoof, A., Boogaerts, M., Van den Berghe, H. and De Wolf-Peeters, C. (1997) "Further characterization of morphologically defined typical and atypical CLL: a clinical, immunophenotypic, cytogenetic and prognostic study on 390 cases", British Journal of Haematology 97, 383-391.
43. Dohner, H., Stilgenbauer, S., Benner, A., Leupolt, E., Krober, A., Bullinger, L., Dohner, K., Bentz, M. and Lichter, P. (2000) "Genomic aberrations and survival in chronic lymphocytic leukemia", New England Journal of Medicine 343, 1910-1916.
44. Dameshek, W. (1967) "Chronic lymphocytic leukemia: an accumulative disease of immunologically incompetent lymphocytes", Blood 29, 566.
45. Damle, R.N., Wasil, T., Fais, F., Ghiotto, F., Valetto, A., Allen, S.L., Buchbinder, A., Budman, D., Dittmar, K., Kolitz, J., Lichtman, S.M., Philip, S., Vinciguerra, V.P., Rai, K.R., Ferraririni, M. and Chiorazzi, N. (1999) "Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia", Blood 94, 1840-1847.
46. Hamblin, T.J., Davis, Z., Gardiner, A., Oscier, D.G. and Stevenson, F.K., (1999) "Unmutated Ig VH genes are associated with a more aggressive form of chronic lymphocytic leukemia", Blood 94, 1848-1854.
47. Naylor, M. and Capra, J.D. (1999) "Mutational status of Ig VH genes provides clinically valuable information in B-cell chronic lymphocytic leukemia", Blood 94, 1837-1839.
48. Hamblin, T.J., Orchard, J.A., Ibbotson, R.E., Davis, Z., Thomas, P.W., Stevenson, F.K. and Oscier, D.G. (2002) "CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease", Blood 99, 1023-1029.
49. D'Arena, G., Musto, P., Cascavilla, N., Dell'Olio, M., Di Renzo, N., Perla, G., Savino, L. and Carotenuto, M. (2001) "CD38 expression correlates with adverse biological features and predicts poor clinical outcome in B-cell chronic lymphocytic leukemia", Leukemia and Lymphoma 42, 109-114.
50. Chevallier, P., Penther, D., Avet-Loiseau, H., Robillard, N., Ifrah, N., Mahe, B., Hamidou, M., Maisonneveuve, H., Moreau, P., Jardel, H., Harousseau, J.L., Bataille, R. and Garand, R. (2002) "CD38 expression and secondary 17p deletion are important prognostic factors in chronic lymphocytic leukaemia", British Journal of Haematology 116, 142-150.
51. Hamblin, T.J., Orchard, J.A., Gardiner, A., Oscier, G., Davis, Z. and Stevenson, F.K. (2000) "Immunoglobulin V genes and CD38 expression in CLL (letter)", Blood 95, 2455-2456.
52. Ibrahim, S., Keating, M., Do, K.A., O'Brien, S., Huh, Y.O., Jilani, I., Lerner, S., Kantarjian, H.M. and Albitar, M. (2001) "CD38 expression as an important prognostic factor in B-cell chronic lymphocytic leukemia", Blood 98, 181-186.
53. Del Poeta, G., Maurillo, L., Venditti, A., Buccisano, F., Epiceno, A.M., Capelli, G., Tamburini, A., Suppo, G., Battaglia, A., Del Principe, M.I., Del Moro, B., Masi, M. and Amadori, S. (2001) "Clinical significance of CD38 expression in chronic lymphocytic leukemia", Blood 98, 2633-2639.
54. Morabito, F., Mangiola, M., Oliva, B., Stelitano, C., Callea, V., Deraglio, S., Iacopino, P., Brugiatelli, M. and Malavasi, F. (2001) "Peripheral blood CD38 expression predicts survival in B-cell chronic lymphocytic leukemia", Leukemia Research 25, 927-932.
55. Heintel, D., Schwarzinger, I., Chizzali-Bonfandin, C., Thalhammer,R., Schwarzmeier, J., Fritzer-Szekeres, M., Weltermann, A., Simonitsch, I., Lechner, K. and Jaeger, U. (2001) "Association of CD38 antigen expression with other prognostic parameters in early stages of chronic lymphocytic leukemia", Leukemia and Lymphoma 42, 1315-1321.
56. Durig, J., Neschar, M., Schmucker, U., Renzing-Kohler, K., Holter, T., Huttmann, A. and Duhrse, U. (2002) "CD38 expression is an important prognostic marker in chronic lymphocytic leukemia", Leukemia 16, 30-35.
57. Damle, R.N., Ghiotto, F., Valetto, A., Albesiano, E., Fais, F., Yan, X,-J., Sison, C.P., Allen, S.L., Kolitz, J., Schulman, P., Vinciguerra, V.P., Budde, P., Frey, J., Rai, K.R., Ferrarini, M. and Chiorazzi, N. (2002) "B-cell chronic lymphocytic leukemia cells express a surface membrane phenotype of activated, antigen-experienced B lymphocytes", Blood 99, 4087-4093.
58. Folkmann, J. (1995) "Angiogenesis in cancer, vascular, rheumatoid and other disease", Nature Medicine 1, 27-31.
59. Vacca, A., Ribatti, D., Roncali, L. and Dammacco, F. (1995) "Angiogenesis in B cell lymphoproliferative diseases. Biological and clinical studies", Leukemia and Lymphoma 20, 27-38.
60. Mangi, M.H. and Newland, A.C. (2000) "Angiogenesis and angiogenic mediators in haematological malignancies", British Journal of Haematology 111, 43-51.
61. Molica, S. (2001) "Angiogenesis in B-cell chronic lymphocytic leukemia: methods of study, clinical significance and prognostic implications", Leukemia and Lymphoma 42, 603-607.
62. Kini, A.R., Kay, N.E. and Peterson, L.C. (2000) "Increased bone marrow angiogenesis in B cell chronic lymphocytic leukemia", Leukemia 14, 1414-1418.
63. Aguayo, A., Kantarjian, H., Manshouri, T., Gidel, C., Estey, E., Thomas, D., Koller, C., Estrov, Z., O'Brien, S., Keating, M., Freireich, E. and Albitar, M. (2000) "Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes", Blood 96, 2240-2245.
64. Aguayo, A., O'Brien, S., Keating, M., Manshouri, T., Gidel, C., Barlogie, B., Beran, M., Koller, C., Kantarjian, H. and Albitar, M. (2000) "Clinical relevance of intracellular vascular endothelial growth factor levels in B-cell chronic lymphocytic leukemia", Blood 96, 768-770.
65. Chen, H., Treweeke, A.T., West, D.C., Till, K.J., Cawley, J.C., Zuzel, M. and Toh, C.H. (2000) "In vitro and in vivo production of vascular endothelial growth factor by chronic lymphocytic leukemia", Blood 96, 3181-3187.